TARGETED

NANOTECHNOLOGY

DRUG DELIVERY

& THERANOSTICS

AGRICULTURAL

NANOTECHNOLOGY

laboratory for targeted drug delivery & personalized medicine technologies

ABOUT US

Our research group is aimed at improving patients’ quality of life and bettering their treatment by developing innovative medical technologies. Specifically, we focus on targeting metastatic cancer with nanotechnology, and on constructing miniature medical devices that couple diagnosis to therapy (theranostic devices). Our lab is headed by Dr Avi Schroeder, who has years of experience in nanotechnology and personalized medicine.

Dr. Avi Schroeder has translational experience with the development of liposome-based clinical systems. He is the author of scientific papers in the field of nanotechnology and medicine. Schroeder is the inventor on 14 patents, and recipient of 20 national and international innovation awards. Dr. Schroeder is a scientific-entrepreneur, starting 5 successful Technion spin-outs.

Our research is supported by:

Phospholipids Research Center

H2020-ERC grant

ERC-STG-2015-680242

Israel Innovation Authority

Israel Science Foundation - ISF

346

Years of Experience

1

Billion Liposomes

58

Countries Visited

24

Staff Children

OUR TEAM

Avi Schroeder

Avi received all three degrees in Chemical Engineering from the Ben-Gurion University. His postdoctoral training at the Massachusetts Institute of Technology (2012). At MIT, Avi and colleagues developed nanoparticles that are capable of autonomously synthesizing proteins upon signal, thereby being a platform for on-site delivery of drugs and preventing damage to healthy organs. In our lab, Avi is building an expert team to work towards improved personalized and targeted medicine.

Janna Shainsky

Janna received her B.Sc. in Biotechnology and Food Engineering from the Technion-Israel Institute of Technology (2007)...
She completed her PhD studies under the supervision of Prof. Ayelet Fishman in the same department. Her research focused on production of valuable chiral sulfoxides using oxidizing enzymes. Janna joined Dr. Schroeder’s group and serves as a lab director and senior scientist, involved in many projects in the lab.

Jeny Shklover

Jeny received BA, MSc and PhD from the Technion. During her PhD obtained under the supervision of Dr. Estee Kurant, she focused on processes involved in dead cells removal at the embryonic central nervous system. In her postdoc at Griffiths lab in UCDAVIS she investigated different aspects of endothelial cells recellularization of xenogeneic scaffolds and development of a novel antigen removal method. Jeny joined Schroeder group in 2019 and serves as lab manager and senior scientist.

Lilach Koren

Lilach received her B.Sc in molecular biochemistry from the Technion (2010). She completed her PhD studies under the supervision of Prof. Ami Aronheim at the Technion Faculty of Medicine. In her thesis she studied the mechanism in which transcription factor ATF3 impacts cardiac hypertrophy. Lilach joined the Schroeder lab in 2018 and is involved in a variety of projects.

Hanan Abumanhal

Hanan graduated from the Hebrew University with a MSc in Pharmaceutical Sciences, gaining two Excellence Awards for her work. Hanan is completing her PhD in our group, focusing on targeting the tumor microenvironment with nanotechnology.

Omer Adir

Omer received his BSc in biochemical engineering at the Technion (2017).
Omer worked as an undergraduate research student in the lab for 3 years focusing on proteolytic enzyme delivery for tissue manipulation.
In his current PhD research, Omer is focusing on development of synthetic cells and cell-free protein synthesis systems.

Maria Poley

Maria received her BSc in Biochemical engineering from the Technion (2017). Maria joined the team in 2015 to work as an undergraduate student. In her current research she is developing a nano-scale platform to study single-cell drug resistance.

Ashima Kajal

Ashima received her bachelors and masters in nanotechnology from Amity University, India.
Ashima joined the lab as an intern for her master’s thesis dissertation in January 2016.
Ashima continues to work as a PhD student to explore and optimize the therapeutic payload a single drug loaded nanoparticle must carry, to be capable of killing a single cancer cell.

Mohammed Alyan

Mohammed received his B.Sc in pharmaceutical engineering from Azrieli college of engineering (2014).
He completed his MSc studies under the supervision of Prof. Avi Domb at the Hebrew University in Medicinal Chemistry (2017).
Mohammed is completing his PhD studies in our group, focusing on active targeting of Head and neck cancer using nanotechnology.

Maya Kaduri

Maya received her B.Sc in Biotechnology and Food Engineering from the Technion (2017). Maya joined our lab in August 2015, and together with Nitzan developed protein producing particles for onsite drug delivery. In her current PhD research, Maya is focusing on targeting neurons at the tumor microenvironment with nanotechnology.

Sivan Arber

Gal Chen

Gal received her B.Sc in Biochemical engineering from the Technion (2018). Gal joined the lab as an undergarduate researcher in September 2017 and participated in the synthetic cell system development. In her current M.Sc. research, Gal continues to work on the development of the synthetic cell system as a base for therapeutic applications.

Aviram

Aviram received his B.Sc. in Biochemical Engineering from the Technion (2018). Aviram started working at the lab in March 2018 as a part of collaboration with a lab from the Hebrew University. Aviram’s current study focuses on developing new generation of RNA delivery systems.

Mor Sela

Mor received her B.Sc in Chemistry from the Ben-Gurion University of the Negev (2019). Mor joined our lab in October 2018, and together with Maya Kaduri (Ph.D. student) developed a system for targeting neurons at the breast tumor microenvironment with nanotechnology. Mor is focusing on liposomal active targeted drug delivery system to the Central Nervous System.

Noga Sharf Pauker

Noga received her B.Sc in Biochemical Engineering at the Technion (2016). Noga has been working for 3 years as R&D engineer in NanoSpun Technologies and has joined the team in February 2019. In her current M.Sc research, Noga is focusing on designing synthetic cells system as a base for therapeutic applications.

Show More

You!

Get in touch for more information about our lab: avids@technion.ac.il

PREVIOUS GRADUATES

Maayan Reshef

Avishai Karny

Nour Zoaby

Dana Da Silva

You!

Get in touch for more information about our lab: avids@technion.ac.il

PREVIOUS GRADUATES

Maayan Reshef

Dana Da Silva

Assaf Zinger

Avishai Karny

Mor Goldfeder

Nitzan Krinsky

Nour Zoaby

Zvi Yaari

Jenny Goldman

Hodaya Printz

CONTACT US

Our Address

Department of Chemical Engineering,

Technion – Israel Institute of Technology

Rooms: 351 (office); 102 (lab)
Haifa 32000, ISRAEL

Dr Avi Schroeder: avids@technion.ac.il

Tel (Avi): +972-77-887-1953 // (lab) +972-77-887-1862

Lilach Koren

Lilach received her B.Sc in molecular biochemistry from the Technion (2010). She completed her PhD studies under the supervision of Prof. Ami Aronheim at the Technion Faculty of Medicine. In her thesis she studied the mechanism in which transcription factor ATF3 impacts cardiac hypertrophy. Lilach joined the Schroeder lab in 2018 and is involved in a variety of projects.